Table 2.
Acute Changes in Ovarian Reserve
| Measure of Ovarian Reserve (N=46) | Baseline Levels Median (interquartile range) | Unadjusted Median Change During Treatment | Unadjusted Percent Change During Treatment n (95%CI) | P value | Adjusted Percent Change During Treatment* n (95% CI) | P value |
|---|---|---|---|---|---|---|
| FSH** | 5.2 mIU/ml (3.3–8.6) | 13.8 mIU/mL | 321 (167 to 565) | <0.0001 | ||
| Treatment < 90 days | 5.0 mlU/mL | 96 (−11 to 332) | 0.088 | 37 (−90 to 1765) | 0.27 | |
| Treatment ≥ 90 days | 29.8 mIU/mL | 554 (225 to 1216) | <0.0001 | 1544 (300 to 5779) | 0.001 | |
| LH | 4.0 mIU/mL (2.0–7.3) | 5.2 mIU/mL | 183 (69 to 373) | <0.0001 | 315 (46 to 1080) | 0.009 |
| AMH | 2.0 ng/mL (1.0–3.5) | −1.7 ng/mL | −89 (−84 to −93) | <0.0001 | −61 (−82 to −6) | 0.018 |
| Estradiol | 41.0 pg/mL (25.3–61.8) | −27.2 pg/mL | −56 (−31 to −71) | .001 | −25 (−69 to 81) | 0.64 |
| Inhibin | 39.7 pg/mL (14.1–84.6) | −19.0 pg/mL | −55 (−25 to −73) | .003 | 37 (−46 to 247) | 0.5 |
| MOV (n=26) | 9.8 cm3 (6.4–13.7) | −4.0 cm3 | −46 (−28 to −60) | <0.0001 | −18 (−55 to 49) | 0.48 |
| AFC (n=26) | 20 follicles (11−41) | −27 follicles | −75 (−56 to −85) | <0.0001 | 24 (−57 to 258) | 0.67 |
Models adjusted for hormone levels at baseline and alkylator score. FSH and Estradiol also adjusted for exogenous hormone use
Overall adjusted change in FSH not reported due to presence of interaction with treatment length